---
title: "Innovation & IP"
description: "SiPore® is a precisely engineered particle platform, protected by a layered intellectual-property portfolio of 7 patent families and 10+ granted patents."
url: "https://sipore.com/science/innovation-ip"
canonical: "https://sipore.com/science/innovation-ip"
markdown_url: "https://sipore.com/science/innovation-ip.md"
site: "SiPore"
publisher: "SiPore Technologies (Sigrid Therapeutics AB)"
language: "en"
updated: "2026-10-02"
---

# Innovation & IP

> SiPore® is a precisely engineered particle platform, protected by a layered intellectual-property portfolio of 7 patent families and 10+ granted patents.

*INNOVATION & IP*

## Precision engineering at the scale of digestion.

SiPore® starts with a familiar material - silica - and turns it into a precisely engineered functional technology.

The innovation lies in the physical design of the particle: its size, structure and controlled pore architecture are engineered to create a specific interaction with digestive enzymes.

That particle design underpins both the function of SiPore® and a growing intellectual-property portfolio protecting the technology and its applications.

[Explore the innovation →](#the-invention)

- 10+ — granted patents
- 7 — patent families in the current portfolio
- MULTIPLE — application areas

*THE INVENTION*

### The material is only the starting point.

Silicon dioxide is the material basis of SiPore®.

What makes SiPore® distinctive is the way that material is engineered.

The particles are manufactured with carefully controlled physical characteristics, including particle size and porosity. The pore structure gives SiPore® its function during digestion.

> **Core statement**
> Silica is the material. The engineered particle is the technology.

- 01 — SILICON DIOXIDE — The material foundation.
- 02 — PARTICLE ENGINEERING — Physical characteristics are controlled during manufacture.
- 03 — PRECISE PORE STRUCTURE — Internal pore architecture is designed for selective interaction with digestive enzymes.
- 04 — FUNCTION DURING DIGESTION — A portion of amylase and lipase can be entrapped, helping make carbohydrate and fat breakdown more gradual.

*PRECISION ENGINEERING*

### Function designed into the structure.

SiPore®’s function is physical.

Its precisely controlled pores create a size-selective environment that allows the particles to interact with digestive enzymes during digestion.

Evidence from preclinical research supports the physical entrapment of enzymes such as amylase and lipase within the pore structure.

This enables SiPore® to influence digestion locally in the gastrointestinal tract without needing to enter the bloodstream.

- Particle size
- Pore structure
- Enzyme fit
- Gut-local function

[See how SiPore® works →](https://sipore.com/technology)

*A LAYERED IP STRATEGY*

### Protecting the platform from multiple angles.

The SiPore® intellectual-property portfolio has been built around multiple aspects of the platform. The goal of this website section is to explain the architecture of that protection, not to interpret individual patent claims.

This layered approach allows the IP portfolio to evolve as the platform moves into new formats, uses and commercial categories.

- MATERIAL & STRUCTURE — Protection relating to highly structured porous silica materials and their properties.
- USE — Protection around applications of porous silica in defined health and functional contexts.
- FORMULATIONS — Protection covering specific SiPore® formulations and ways of bringing the technology into finished products.
- APPLICATIONS — Additional patent families extend the platform into areas beyond the original metabolic-health application.

*PATENT PORTFOLIO*

### Seven patent families across multiple application areas.

The current portfolio shown in the supplied September 2026 material spans metabolic health, oral health and additional applications.

- Medical use — FAMILY 1 • METABOLIC HEALTH
- Composition of matter — FAMILY 2 • METABOLIC HEALTH
- SiPore21 formulation — medical use — FAMILY 3 • METABOLIC HEALTH
- SiPore21 formulation — food — FAMILY 4 • METABOLIC HEALTH
- Oral-care applications — FAMILY 5 • ORAL HEALTH
- Chewable formats — FAMILY 6 • ORAL HEALTH
- Antibacterial applications — FAMILY 7 • ADDITIONAL APPLICATIONS

*PLATFORM INNOVATION*

### One engineered platform. Multiple application areas.

The physical properties of SiPore® can be engineered for different functional applications.

Metabolic health is the most clinically developed expression of the platform today, while the underlying material- and pore-engineering capabilities create opportunities in additional categories.

- METABOLIC HEALTH — ESTABLISHED / MOST ADVANCED
- ORAL HEALTH — EXPANDING
- PET HEALTH — RESEARCH & PARTNERSHIP
- FUNCTIONAL FOOD — EXPLORATORY
- PROFESSIONAL ORAL HEALTH — LONGER-TERM

- METABOLIC HEALTH — SiPore® has been developed extensively for metabolic-health applications, with more than 15 years of research, human clinical evaluation and commercial products using the technology.
- ORAL HEALTH — The SiPore® platform is also being developed for oral-care applications. The current IP portfolio includes patent families covering oral-care compositions and chewable formats.
- PET HEALTH — The platform is also being evaluated for applications in animal health. The combination of engineered material science and local action creates opportunities to investigate new uses of SiPore® beyond human metabolic health.
- FUNCTIONAL FOOD — Because SiPore® is designed to work with the meal, the platform may also lend itself to future food-format applications. This could allow the meal-companion principle to be integrated directly into new product formats.
- PROFESSIONAL ORAL HEALTH — Future applications may also extend into professional oral-health environments and specialist formulations. These remain development opportunities rather than current SiPore® consumer applications.

*THE PLATFORM MODEL*

### SiPore® can reach the market in different ways.

- OWNED CONSUMER BRANDS — SIGRID brings SiPore® to consumers through products sold via SigridLife.com.
- HEALTHCARE PROFESSIONALS — SiPore® Pro brings the technology into practitioner-facing products and professional education.
- PARTNERS — External companies can develop products using the technology under the Powered by SiPore® endorsement.

[Explore Applications →](https://sipore.com/applications)

*FORMAT-INDEPENDENT TECHNOLOGY*

### The function belongs to the particle, not the package.

SiPore® is not defined by a capsule, gel, powder or any other single delivery format.

The technology resides in the engineered porous particle.

That creates flexibility to develop different finished-product formats while preserving the central SiPore® principle: precision-engineered material designed for a specific local function.

Different formats. One engineered platform.

*SCIENCE + ENGINEERING + IP*

### Research creates new IP. IP enables new research.

SiPore® began with a material-science question:

↺ back to RESEARCH

> **The question**
> Can porous silica be engineered to perform a controlled biological function?
> Research into that question led to new particle designs, new applications and new intellectual property. As the platform develops, the same cycle continues.

- RESEARCH — Understand a biological or functional opportunity.
- ENGINEERING — Design the particle structure for the intended role.
- PROTECT — Build intellectual-property protection around the innovation.
- APPLY — Translate the technology into products and new application areas.
- LEARN — Generate new evidence and identify the next opportunity.

*PARTNERSHIPS & LICENSING*

### Build with SiPore®.

SiPore Technologies develops and protects the SiPore® platform and works with partners to bring the technology into new products, categories and markets.

For licensing, product development or strategic partnership discussions:

[Partner with us →](mailto:partnerships@sipore.com)

[partnerships@sipore.com →](mailto:partnerships@sipore.com)

*RELATED SCIENCE*

- RESEARCH & EVIDENCE — See how SiPore® has progressed from mechanism research to human clinical evaluation.
- PUBLICATIONS — Browse the peer-reviewed science behind the platform.
- TECHNOLOGY — See how the engineered SiPore® particle works during digestion.

### The innovation is not the existence of silica.

It is the precision engineering of the particle and its pore structure - and the intellectual property built around that engineering and its applications.

## How to cite

SiPore Technologies (Sigrid Therapeutics AB). “Innovation & IP”. SiPore, 2026-10-02. https://sipore.com/science/innovation-ip (accessed <date>).

Use the trademarks as written: SiPore®, Carb Fence™. For the SHINE trial, cite the peer-reviewed publication in *eClinicalMedicine* (The Lancet Discovery Science, 2026) rather than this page.

## Company & contact

- **Company:** SiPore Technologies — legal entity Sigrid Therapeutics AB (Swedish org.nr [556958-3023](https://www.allabolag.se/foretag/sigrid-therapeutics-ab/sundbyberg/forskning/2K3ZHRJI5YE3M))
- **Stockholm headquarters:** Vasagatan 14A, 172 61 Sundbyberg, Sweden ([map](https://www.google.com/maps/search/?api=1&query=Vasagatan%2014A%2C%20172%2061%20Sundbyberg%2C%20Sweden))
- **General enquiries:** [contact@sipore.com](mailto:contact@sipore.com)
- **Partnerships & licensing:** [partnerships@sipore.com](mailto:partnerships@sipore.com)
- **Origin:** Founded in Stockholm, Sweden
- **Taglines:** “The meal companion for modern food.” · “Same meal. Less impact.” · “Scandinavian science. Global impact.” · “Precision science for the modern meal.”
- **About:** SiPore® is a patented meal-companion technology designed to reduce the impact of modern meals at the level of digestion.

**Our sites** — all sites owned and operated by Sigrid Therapeutics AB:

- [SiPore.com](https://www.sipore.com/): Technology, science & partnerships
- [SiPorePro.com](https://www.siporepro.com/): Practitioner products & professional resources
- [SigridLife.com](https://sigridlife.com/): SIGRID consumer products
- [SigridStabiliser.se](https://sigridstabiliser.se/): SIGRID Sweden

---
[View on site](https://sipore.com/science/innovation-ip) · [Site index for agents (llms.txt)](https://sipore.com/llms.txt)
